Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPO
501
DELISTED
BROOKFIELD OFFICE PROPERTIES. INC
BPO
| $17.7M | 0.05% |
+1,061,450
| New | +$18.7M |
|
502
Imperial Oil
IMO
$63B
| $17.6M | 0.05% |
+461,000
| New | +$18M |
|
|
LUFK
503
DELISTED
LUFKIN IND INC
LUFK
| $17.6M | 0.05% |
+198,662
| New | +$17.2M |
|
504
Melco Resorts & Entertainment
MLCO
$2.14B
| $17.5M | 0.05% |
+782,200
| New | +$18.5M |
|
|
KMR
505
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
| $17.3M | 0.05% |
+228,964
| New | +$17.5M |
|
|
CEO
506
DELISTED
CNOOC Limited
CEO
| $17.3M | 0.05% |
+103,400
| New | +$18.5M |
|
507
Western Digital
WDC
$159B
| $17.3M | 0.05% |
+368,588
| New | +$16.1M |
|
508
Energy Transfer Partners
ET
$72B
| $17.2M | 0.05% |
+1,152,052
| New | +$16.8M |
|
509
Herbalife
HLF
$1.23B
| $17.2M | 0.05% |
+761,800
| New | +$16.2M |
|
510
PetMed Express
PETS
$42.7M
| $17.1M | 0.04% |
+1,354,115
| New | +$17.7M |
|
511
CSX Corp
CSX
$92.5B
| $17M | 0.04% |
+2,194,500
| New | +$18M |
|
512
Oceaneering
OII
$5.1B
| $16.9M | 0.04% |
+234,400
| New | +$16.4M |
|
|
HIMX
513
Himax Technologies
HIMX
$2.64B
| $16.9M | 0.04% |
+3,232,700
| New | +$19.9M |
|
514
Seaboard Corp
SEB
$4.05B
| $16.9M | 0.04% |
+6,231
| New | +$16.9M |
|
515
Rollins
ROL
$17.7B
| $16.8M | 0.04% |
+2,192,906
| New | +$15.8M |
|
516
IDT Corp
IDT
$1.61B
| $16.7M | 0.04% |
+1,499,623
| New | +$14.7M |
|
517
Spectrum Brands
SPB
$2.02B
| $16.6M | 0.04% |
+291,300
| New | +$17M |
|
518
Lincoln Electric
LECO
$15.5B
| $16.6M | 0.04% |
+289,038
| New | +$16.1M |
|
519
Fortune Brands Innovations
FBIN
$5.8B
| $16.6M | 0.04% |
+499,824
| New | +$16.6M |
|
|
ACC
520
DELISTED
American Campus Communities, Inc.
ACC
| $16.5M | 0.04% |
+405,928
| New | +$17.4M |
|
|
OKS
521
DELISTED
Oneok Partners LP
OKS
| $16.5M | 0.04% |
+332,986
| New | +$17.5M |
|
522
Edwards Lifesciences
EW
$53.6B
| $16.5M | 0.04% |
+1,471,800
| New | +$17.4M |
|
|
SNV
523
DELISTED
Synovus
SNV
| $16.5M | 0.04% |
+805,136
| New | +$15.3M |
|
524
American States Water
AWR
$3.47B
| $16.5M | 0.04% |
+613,200
| New | +$16.7M |
|
525
Nasdaq
NDAQ
$53.3B
| $16.4M | 0.04% |
+1,504,998
| New | +$15.3M |
|
Similar funds
Jim Simons's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.